NKGen Biotech Inc (NASDAQ:NKGN) currently has a daily average trading volume of 1.91M but it saw 1936941 shares traded in last market. With a market cap of 21.57M USD, the company’s current market price of $0.48 came falling about -9.45 while comparing to the previous closing price of $0.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.06 and as low as $0.20.
Taking a look at 20-day trading activity of NKGen Biotech Inc (NKGN) gives us an average price of $0.5126, while its current price level is -88.18% below from 52-week high level whereas it is 136.87% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5435 while that of 200 days or SMA-200 reads an average of $0.7736. A closer look into the stock’s movement over the week reveals that its volatility is standing at 49.88% during that period while stretching the period over a month that decreases to 19.18%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 47.04 which implies that the stock is in neutral territory.
Over the week, NKGN’s stock price is moving 26.36% up while it is 9.02% when we observe its performance for the past one month. Year-to-date it is -26.76% down and over the past year, the stock is showing a downside performance of -68.11%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, NKGen Biotech Inc’s total number of outstanding shares is 44.95M with 39.40% of that held by the insiders while 21.93% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -118.66%. Stock’s beta reads 0.48. Its return on asset (ROA) is -196.21% on average.
